In non-squamous NSCLC (ns-NSCLC), PTPRD mutation patients also had a longer median PFS (324 vs 63 days, HR=0.36, p=0.0152, Fig. 2c). This evidence concerns the gene PTPRD and non-small cell lung carcinoma.